Actress and socialite Fella Makafui was allegedly arrested by the Police following a 6-month-long investigation by ISPYGH 247. The investigative piece which was a collaboration between the media firm and the Pharmacy Council allegedly led to the arrest of the YOLO actress.
A statement released by the firm on May 23, revealed that the actress confessed to selling “registered drugs” following her arrest on May 22. She is accused of using social media especially, TikTok and Instagram to advertise and sell the drugs.
According to the statement signed by Akwasi Koranteng, Fella Makafui used her platform to sell “unregistered drugs”, make “False” adverts and publish “unapproved adverts by the Food and Drugs Authority (FDA).”
The statement added that Fella has since been granted bail.
Read the full statement on the arrest of Fella Makafui
ISPYGH 247, a renowned investigative documentary filmmaking firm, in collaboration with the Pharmacy Council Ghana, has successfully apprehended Makafui Precious Fella, a social media influencer/Actress, for unlawful activities related to the sale of unregistered drugs yesterday, 22nd May 2024.
After six months of meticulous monitoring of Fella’s social media posts on TikTok and Instagram, Akwasi Koranteng and his team of undercover investigative journalists from ISPYGH 247 gathered evidence of her illegal activities, including:
– Selling unregistered drugs
– False advertising
– Publishing unapproved adverts by the Food and Drugs Authority (FDA)
Upon arrest, a range of products were seized at her Mempeasem shop, including:
1. Fertility Tea (Fibroid And Womb Tea)
2. Butt And Hips Enlargement Syrup
3. Butt And Hip Enlargement Oil
4. Booty Cream
5. Booty Scrub
10.Spice Herbal Infection Mixture
11.Yoni Wash Gel
12.Orgasmic Gel
13.Weight Gain Syrup
14.Spice Coded Powder
15. Tiger Herbal Mixture
16.Sweet Drip Honey
During questioning, Fella confessed that most of the drugs she sold were not registered by the FDA. She has since been granted bail.
This joint operation aims to protect the public from harmful and unapproved products, ensuring the highest level of pharmaceutical care and competent providers.
Further updates will be provided soon.
